Warning: Counterfeit Ciprobay Tablets Found in Egyptian Pharmaceutical Market

Warning: Counterfeit Ciprobay Tablets Found in Egyptian Pharmaceutical Market

Written by Walid Abdel Salam Wednesday, August 09, 2023 11:44 AM Issued Egyptian Medicines Authorityan urgent warning to citizens about the Ciprobay tablet, confirming that there are counterfeit packages of this product in the pharmaceutical market, and citizens must contact the authority in the event of purchasing this product or contact the hotline. Ciprobay tablet … Read more

Understanding Potassium Deficiency: Symptoms, Causes, and Health Complications

Understanding Potassium Deficiency: Symptoms, Causes, and Health Complications

It is happening Potassium deficiency When a person has abnormally low levels of potassium in the body. It is also called hypokalemia. Potassium is a mineral that helps regulate fluids in the body and helps muscles and nerves function properly. It is found inside cells and is essential for good health.Here are symptoms Potassium deficiency … Read more

Rare Side Effect: Green and Hairy Tongue in Ohio Man Linked to Smokings and Antibiotics

Rare Side Effect: Green and Hairy Tongue in Ohio Man Linked to Smokings and Antibiotics

Jakarta – A man’s tongue in Ohio, USA, has turned green and hairy thought to be a rare side effect of smoking tobacco and taking antibiotics. The 64-year-old man went to a primary care clinic a few weeks after noticing his tongue was starting to change color. According to a study report published in the … Read more

Pfizer Warns of Shortage in Antibiotics for Treating Syphilis and Bacterial Infections

Pfizer Warns of Shortage in Antibiotics for Treating Syphilis and Bacterial Infections

Medicine (illustration). A spike in syphilis and other bacterial infections has hit an already depleted supply of antibiotics. REPUBLIKA.CO.ID, JAKARTA — The American pharmaceutical company, Pfizer, has warned that the drug used to treat syphilis and other bacterial infections in children may be discharged by the end of this June. A spike in syphilis and … Read more

“Man Successfully Treated for Moraxella-Associated Infectious Scleritis: A BMJ Case Report”

“Man Successfully Treated for Moraxella-Associated Infectious Scleritis: A BMJ Case Report”

A man in his 50s was treated for Moraxella-associated infectious scleritis, as reported by BMJ Case Reports authors. The patient presented to the eye emergency department with a painful and red left eye, accompanied by a foreign body sensation and photophobia. The patient’s medical history included a diagnosis of chronic lymphocytic leukaemia in 2020 and … Read more

“Pig Almond Microorganisms May Be Key to Antibiotic-Free Pig Farming”

“Pig Almond Microorganisms May Be Key to Antibiotic-Free Pig Farming”

Microorganisms from pig almonds may be useful as probiotics instead of antibiotics to prevent infections in pigs. This is what Isabela Fernandes de Oliveira says in the WUR journal Resource. She obtained her PhD with her study of new ways to reduce antibiotic use on farms. Among the micro-organisms that occur naturally in the animals, … Read more

“Understanding Types of Antibiotics and Their Functions for Effective Treatment”

“Understanding Types of Antibiotics and Their Functions for Effective Treatment”

Types of antibiotics and their functions really need to be understood by the public. / Photo: illustration/Cathay Drug JAKARTA – Type antibiotics and its function is very necessary to understand the community. This is so that people can know more about the antibiotics that may be prescribed to them when they visit the hospital. To … Read more

Entasis Therapeutics revealed its investigational therapy Sulbactam-durlobactam (SUL-DUR) performed better than colistin in treating Acinetobacter baumannii infections in a phase 3 trial. SUL-DUR, which has been submitted for new drug application to the US Food and Drug Administration, could address the virus, which the WHO and the CDC recognises as a highest unmet medical need, and could be available from May 2023.

Entasis Therapeutics revealed its investigational therapy Sulbactam-durlobactam (SUL-DUR) performed better than colistin in treating Acinetobacter baumannii infections in a phase 3 trial. SUL-DUR, which has been submitted for new drug application to the US Food and Drug Administration, could address the virus, which the WHO and the CDC recognises as a highest unmet medical need, and could be available from May 2023.

Acinetobacter baumannii is a bacteria that has become a major challenge in hospitals worldwide due to its resistance to commonly used antibiotics. In recent years, the emergence and spread of drug-resistant strains of Acinetobacter have further complicated treatment options, making it increasingly difficult to manage infections caused by this pathogen. However, a new drug called … Read more

WHO identifies cancer risks associated with these drugs

WHO identifies cancer risks associated with these drugs

All medicines have some kind of secondary effect, either more or less serious. This is something that everyone knows, but sometimes there are some drugs that are necessary, so there is no choice but to take them. However, it is important that the benefits that this medicine will produce are greater than the harm it … Read more